SCHOTT Pharma AG & Co. KGaA

48
Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A3ENQ51
EUR
13.50
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Sep'25
Sep'24
Dec'23
Sep'23
Dec'22
Sep'22
No of Months
12
12
12
12
12
12
Operating Income
986.00
957.00
899.00
898.00
821.00
821.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
986.00
957.00
899.00
898.00
821.00
821.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
254.00
238.00
0.00
1.00
0.00
1.00
Operating Expenses
19.00
13.00
0.00
6.00
0.00
2.00
General and Administration Expenses
129.00
124.00
0.00
122.00
0.00
110.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
811.00
783.00
0.00
732.00
0.00
659.00
Operating Profit (PBDIT) excl Other Income
174.00
173.00
899.00
166.00
821.00
161.00
Other Income
17.00
11.00
0.00
10.00
0.00
-2.00
Operating Profit (PBDIT)
273.00
249.00
0.00
221.00
0.00
214.00
Interest
19.00
13.00
0.00
6.00
0.00
2.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
79.00
64.00
0.00
46.00
0.00
55.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
173.00
171.00
0.00
174.00
0.00
145.00
Provision for Tax
40.00
33.00
0.00
33.00
0.00
32.00
Profit After Tax
146.00
149.00
152.00
151.00
0.00
125.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.97
0.99
0.00
1.01
0.00
0.83
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2025 is 3.04% vs NA in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2025 is 0.45% vs NA in Sep 2024

stock-summary

Interest

YoY Growth in year ended Sep 2025 is 49.74% vs NA in Sep 2024

stock-summary

Profit After Tax

YoY Growth in year ended Sep 2025 is -2.16% vs NA in Sep 2024

Compare Profit and Loss Results of SCHOTT Pharma AG & Co. KGaA
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
No of Months
12
12
Operating Income
986.00
0
986.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
986.00
0
986.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
254.00
0
254.00
0%
Operating Expenses
19.00
0
19.00
0%
General and Administration Expenses
129.00
0
129.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
811.00
0
811.00
0%
Operating Profit (PBDIT) excl Other Income
174.00
0.00
174.00
0%
Other Income
17.00
0
17.00
0%
Operating Profit (PBDIT)
273.00
0
273.00
0%
Interest
19.00
0
19.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
79.00
0
79.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
173.00
0
173.00
0%
Provision for Tax
40.00
0
40.00
0%
Profit After Tax
146.00
0
146.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.9724
0
0.97
0%
Profit And Loss - Net Sales
Net Sales 986.21 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 3.04% vs NA in Sep 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 174.67 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 0.45% vs NA in Sep 2024

Profit And Loss - Interest
Interest 19.75 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 49.74% vs NA in Sep 2024

Profit And Loss - Profit After Tax
Profit After Tax 146.45 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is -2.16% vs NA in Sep 2024